A study found no correlation between high-density lipoprotein cholesterol levels and the risk of developing movement disorders in patients taking antipsychotics. Researchers investigated this association in 89 adult patients at a psychiatric facility and found that only eight patients had movement disorder symptoms. There was no significant association between Abnormal Involuntary Movement Scale scores and HDL-C levels. The study suggests focusing on removing offending medications rather than hypothesizing about physiological factors like HDL-C when managing drug-induced movement disorders. Early recognition can lead to rapid intervention and reduced risk of permanent symptoms. The study was published in Innovations in Clinical Neuroscience in 2024.
Source link
Study reveals no link between high-density lipoprotein cholesterol and movement disorders
